![James Neal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Neal
Directeur/Membre du Conseil chez
PROCESSA PHARMACEUTICALS, INC.
Fortune : 2 372 $ au 31/05/2025
Profil
M. James R. Neal est président du conseil d'administration de Palisade Bio, Inc. et directeur général et administrateur de XOMA Corp. et directeur général de XOMA (US) LLC. Il est membre du conseil d'administration de Leading Biosciences, Inc. et de XOMA Corp. Auparavant, M. Neal a été employé en tant que président et directeur général d'Entelos, Inc. et directeur général et administrateur d'Iconix Biosciences, Inc. et vice-président exécutif des ventes, du marketing et du développement commercial d'Incyte Genomics Inc. /Micoarray Operations/, directeur général de The Solaris Group, partenaire d'Eli Lilly & Co. Ltd, un partenaire de GlaxoSmithKline Pharmaceuticals SA (Belgique), un directeur de Monsanto Co. et un directeur général de la US Food & Drug Administration. Il est titulaire d'un diplôme de premier cycle de l'université du Manitoba, d'un diplôme d'études supérieures de l'université du Manitoba et d'un MBA de l'université Washington de Saint-Louis.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/06/2026 | 1 021 ( 0,04 % ) | 1 960 $ | 30/06/2026 | |
AKARI THERAPEUTICS PLC 0,08 % | 01/06/2026 | 41 144 000 ( 0,08 % ) | 411 $ | 31/05/2025 |
Postes actifs de James Neal
| Sociétés | Poste | Début |
|---|---|---|
| MONTEREY INNOVATION ACQUISITION CORP. | Directeur/Membre du Conseil | 09/03/2023 |
| PROCESSA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 16/07/2022 |
| AKARI THERAPEUTICS, PLC | Directeur/Membre du Conseil | 13/11/2024 |
XOMA (US) LLC
 XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Directeur Général | - |
Anciens postes connus de James Neal
| Sociétés | Poste | Fin |
|---|---|---|
| PEAK BIO, INC. | Directeur/Membre du Conseil | 14/11/2024 |
| PALISADE BIO, INC. | Président | 09/02/2024 |
| XOMA ROYALTY CORPORATION | Directeur Général | 01/01/2023 |
| PALISADE BIO, INC. | Président | 29/04/2021 |
Entelos, Inc.
 Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Directeur Général | 11/09/2009 |
Formation de James Neal
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Monsanto Co.
 Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
Iconix Biosciences, Inc.
 Iconix Biosciences, Inc. BiotechnologyHealth Technology Provides toxicogenomics products and services | Health Technology |
Entelos, Inc.
Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Commercial Services |
The Solaris Group
 The Solaris Group Chemicals: AgriculturalProcess Industries Manufactures plant food | Process Industries |
Incyte Genomics Inc. /Micoarray Operations/
 Incyte Genomics Inc. /Micoarray Operations/ Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical drug discovery and development services | Commercial Services |
University of Manitoba
 University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Manufactures biotherapeutic products | Health Technology |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Health Technology |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Leading Biosciences, Inc.
 Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Commercial Services |
Palisade Bio, Inc.
 Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Monterey Innovation Acquisition Corp.
 Monterey Innovation Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Peak Bio, Inc.
 Peak Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics to treat oncology and inflammatory diseases | Health Technology |
